← All trials
NCT05343507
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2022
- Primary completion
- May 1, 2025
- Completion date
- May 1, 2026
- First posted
- Apr 25, 2022
- Last posted
- Nov 7, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LiegeLead sponsor
- University of LiegeCollaborator
- University of LiegeReponsible party - principal investigator
- Université catholique de LouvainCollaborator
- University of LiegeSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.